Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.05
THC's Cash-to-Debt is ranked lower than
84% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. THC: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
THC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 0.38
Current: 0.05
0
0.38
Equity-to-Asset 0.02
THC's Equity-to-Asset is ranked lower than
93% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. THC: 0.02 )
Ranked among companies with meaningful Equity-to-Asset only.
THC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.27 Max: 0.43
Current: 0.02
0.01
0.43
Interest Coverage 1.25
THC's Interest Coverage is ranked lower than
92% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. THC: 1.25 )
Ranked among companies with meaningful Interest Coverage only.
THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.24 Max: 1.82
Current: 1.25
0.66
1.82
Piotroski F-Score: 5
Altman Z-Score: 0.96
WACC vs ROIC
4.58%
7.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 6.21
THC's Operating Margin % is ranked lower than
57% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. THC: 6.21 )
Ranked among companies with meaningful Operating Margin % only.
THC' s Operating Margin % Range Over the Past 10 Years
Min: 3.41  Med: 5.98 Max: 8.21
Current: 6.21
3.41
8.21
Net Margin % -0.98
THC's Net Margin % is ranked lower than
79% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. THC: -0.98 )
Ranked among companies with meaningful Net Margin % only.
THC' s Net Margin % Range Over the Past 10 Years
Min: -1.21  Med: 0.18 Max: 13.5
Current: -0.98
-1.21
13.5
ROE % -34.48
THC's ROE % is ranked lower than
94% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. THC: -34.48 )
Ranked among companies with meaningful ROE % only.
THC' s ROE % Range Over the Past 10 Years
Min: -55.97  Med: 2.68 Max: 92.79
Current: -34.48
-55.97
92.79
ROA % -0.79
THC's ROA % is ranked lower than
78% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. THC: -0.79 )
Ranked among companies with meaningful ROA % only.
THC' s ROA % Range Over the Past 10 Years
Min: -1.05  Med: 0.19 Max: 13.89
Current: -0.79
-1.05
13.89
ROC (Joel Greenblatt) % 14.71
THC's ROC (Joel Greenblatt) % is ranked lower than
58% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. THC: 14.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
THC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.8  Med: 12.1 Max: 15.25
Current: 14.71
4.8
15.25
3-Year Revenue Growth Rate 21.90
THC's 3-Year Revenue Growth Rate is ranked higher than
87% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. THC: 21.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
THC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -13.7  Med: 0.3 Max: 32.4
Current: 21.9
-13.7
32.4
3-Year EBITDA Growth Rate 35.20
THC's 3-Year EBITDA Growth Rate is ranked higher than
92% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. THC: 35.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
THC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -47.1  Med: 9.4 Max: 37.9
Current: 35.2
-47.1
37.9
3-Year EPS without NRI Growth Rate 15.80
THC's 3-Year EPS without NRI Growth Rate is ranked higher than
62% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. THC: 15.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
THC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72.8  Med: -0.4 Max: 57
Current: 15.8
-72.8
57
GuruFocus has detected 5 Warning Signs with Tenet Healthcare Corp $THC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» THC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-01)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

THC Guru Trades in Q1 2016

David Tepper 348,405 sh (New)
George Soros 31,700 sh (New)
Mario Gabelli 15,050 sh (+0.07%)
Larry Robbins 17,890,230 sh (unchged)
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
» More
Q2 2016

THC Guru Trades in Q2 2016

Joel Greenblatt 545,902 sh (New)
Larry Robbins 17,890,230 sh (unchged)
George Soros Sold Out
David Tepper Sold Out
Mario Gabelli 15,000 sh (-0.33%)
» More
Q3 2016

THC Guru Trades in Q3 2016

Paul Tudor Jones 45,786 sh (New)
Steven Cohen 415,400 sh (New)
Mario Gabelli 15,000 sh (unchged)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt 22,489 sh (-95.88%)
» More
Q4 2016

THC Guru Trades in Q4 2016

George Soros 13,500 sh (New)
Paul Singer 1,494,358 sh (New)
Michael Price 250,000 sh (New)
Jim Simons 1,325,875 sh (New)
Larry Robbins 17,890,230 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli Sold Out
Paul Tudor Jones 24,300 sh (-46.93%)
Steven Cohen 5,300 sh (-98.72%)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NAS:AMED, NYSE:SEM, NAS:TVTY, NYSE:AMN, NYSE:CYH, NAS:LHCG, NAS:SGRY, NYSE:USPH, NAS:SCAI, OTCPK:COLRY, NAS:AFAM, NAS:PRSC, OTCPK:CGMVF, OTCPK:RLGHF, NAS:LPNT, OTCPK:MFCSF, NAS:ADUS, OTCPK:CMBGF, NAS:BIOS, NYSE:AAC » details
Traded in other countries:THC1.Germany,
Headquarter Location:USA
Tenet Healthcare Corp is a health care services company. The Company, together with its subsidiaries, operates healthcare delivery networks in urban and suburban markets in the United States.

Based in Dallas, Tenet Healthcare is one of the largest acute-care firms in the U.S., accounting for roughly 2% of the country's hospital admissions. It operates 79 acute-care hospitals with more than 20,000 beds, as well as over 475 ambulatory surgery centers, diagnostic imaging centers, and urgent care centers, and a revenue cycle subsidiary called Conifer. Tenet has facilities in numerous states, with most of its total operations in California, Florida, and Texas. Outpatient services make up about 36% of Tenet's patient revenue.

Top Ranked Articles about Tenet Healthcare Corp

Amedisys Announces Definitive Agreement to Acquire Six Home Health and Hospice Care Centers from Tenet Healthcare

BATON ROUGE, La., March 01, 2017 (GLOBE NEWSWIRE) --  Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home health care, hospice and personal care companies, today announced that it has signed a definitive agreement to acquire Tenet Healthcare’s (:THC) home health and hospice operations in Arizona, Illinois, Massachusetts and Texas.
“This acquisition gives Amedisys an incredible opportunity to continue our goal of providing high-quality post-acute services in key markets,” stated President and Chief Executive Officer Paul Kusserow. “We look forward to the opportunity to work with Tenet in these markets to improve the delivery of care and management of patients across the care continuum.” “Amedisys shares our commitment to serving patients, employees and the community,” stated Trevor Fetter, Chairman and Chief Executive Officer of Tenet Healthcare. “We are transferring these local operations of healthcare service providers to Amedisys so that high quality home health and hospice services will continue to be available within the communities they serve.” Since December 2015, Amedisys has announced six acquisitions, deploying approximately $125 million in capital and contributing approximately $145 million in revenue.  Forward-Looking Statements: When included in this press release, words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to identify forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a variety of risks and uncertainties that could cause actual results to differ materially from those described therein. These risks and uncertainties include, but are not limited to the following: changes in Medicare and other medical payment levels, our ability to open care centers, acquire additional care centers and integrate and operate these care centers effectively, changes in or our failure to comply with existing Federal and State laws or regulations or the inability to comply with new government regulations on a timely basis, competition in the healthcare industry, our ability to integrate our personal care segment into our business efficiently, changes in the case mix of patients and payment methodologies, changes in estimates and judgments associated with critical accounting policies, our ability to maintain or establish new patient referral sources, our ability to attract and retain qualified personnel, changes in payments and covered services due to the economic downturn and deficit spending by federal and state governments, future cost containment initiatives undertaken by third-party payors, our access to financing, our ability to meet debt service requirements and comply with covenants in debt agreements, business disruptions due to natural disasters or acts of terrorism, our ability to integrate, manage and keep our information systems secure, our ability to comply with requirements stipulated in our corporate integrity agreement and changes in law or developments with respect to any litigation relating to the Company, including various other matters, many of which are beyond our control. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on any forward-looking statement as a prediction of future events. We expressly disclaim any obligation or undertaking and we do not intend to release publicly any updates or changes in our expectations concerning the forward-looking statements or any changes in events, conditions or circumstances upon which any forward-looking statement may be based, except as required by law. About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 16,000 employees, in 420 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 385,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.  About Tenet Healthcare
Tenet Healthcare Corporation is a diversified healthcare services company with 130,000 employees united around a common mission: to help people live happier, healthier lives. Through its subsidiaries, partnerships and joint ventures, including United Surgical Partners International, the company operates 80 general acute care hospitals, 20 short-stay surgical hospitals and approximately 470 outpatient centers in the United States, as well as nine facilities in the United Kingdom. Tenet’s Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks, physician groups, self-insured organizations and health plans. For more information, please visit www.tenethealth.com
Kendra Kimmons 
Managing Director of Communications 
225-299-3708 
[email protected]

Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 13.11
THC's Forward PE Ratio is ranked higher than
84% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 18.73 vs. THC: 13.11 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 3.73
THC's PB Ratio is ranked lower than
71% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. THC: 3.73 )
Ranked among companies with meaningful PB Ratio only.
THC' s PB Ratio Range Over the Past 10 Years
Min: 1.39  Med: 5.25 Max: 100.25
Current: 3.73
1.39
100.25
PS Ratio 0.08
THC's PS Ratio is ranked higher than
97% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. THC: 0.08 )
Ranked among companies with meaningful PS Ratio only.
THC' s PS Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.3 Max: 0.56
Current: 0.08
0.05
0.56
Price-to-Free-Cash-Flow 6.04
THC's Price-to-Free-Cash-Flow is ranked higher than
92% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. THC: 6.04 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
THC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.06  Med: 39.62 Max: 514.15
Current: 6.04
2.06
514.15
Price-to-Operating-Cash-Flow 2.77
THC's Price-to-Operating-Cash-Flow is ranked higher than
95% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. THC: 2.77 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
THC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.31  Med: 6.48 Max: 15.63
Current: 2.77
1.31
15.63
EV-to-EBIT 13.87
THC's EV-to-EBIT is ranked higher than
68% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. THC: 13.87 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -273.8  Med: 13.7 Max: 1337.9
Current: 13.87
-273.8
1337.9
EV-to-EBITDA 8.17
THC's EV-to-EBITDA is ranked higher than
84% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. THC: 8.17 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8.1 Max: 22.6
Current: 8.17
-34
22.6
Shiller PE Ratio 20.94
THC's Shiller PE Ratio is ranked higher than
62% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.31 vs. THC: 20.94 )
Ranked among companies with meaningful Shiller PE Ratio only.
THC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.05  Med: 54.61 Max: 301.91
Current: 20.94
20.05
301.91
Current Ratio 1.30
THC's Current Ratio is ranked higher than
50% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. THC: 1.30 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.38 Max: 1.96
Current: 1.3
0.88
1.96
Quick Ratio 1.22
THC's Quick Ratio is ranked higher than
52% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. THC: 1.22 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 0.85  Med: 1.3 Max: 1.85
Current: 1.22
0.85
1.85
Days Inventory 9.27
THC's Days Inventory is ranked higher than
69% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. THC: 9.27 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.92  Med: 10.35 Max: 13.35
Current: 9.27
8.92
13.35
Days Sales Outstanding 53.89
THC's Days Sales Outstanding is ranked lower than
68% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. THC: 53.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 62.54
Current: 53.89
46.89
62.54
Days Payable 38.87
THC's Days Payable is ranked lower than
52% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. THC: 38.87 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 38.87  Med: 47.66 Max: 56.74
Current: 38.87
38.87
56.74

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.00
THC's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. THC: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
THC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.9  Med: -0.7 Max: 7.3
Current: -1
-21.9
7.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.69
THC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
88% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. THC: 0.69 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
THC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.66  Med: 1.62 Max: 12.57
Current: 0.69
0.66
12.57
Price-to-Median-PS-Value 0.26
THC's Price-to-Median-PS-Value is ranked higher than
96% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. THC: 0.26 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
THC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21  Med: 1.95 Max: 5.98
Current: 0.26
0.21
5.98
Earnings Yield (Greenblatt) % 7.23
THC's Earnings Yield (Greenblatt) % is ranked higher than
73% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. THC: 7.23 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
THC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.1  Med: 7.1 Max: 15.7
Current: 7.23
0.1
15.7
Forward Rate of Return (Yacktman) % 38.16
THC's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. THC: 38.16 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
THC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -103.1  Med: 0.5 Max: 38.5
Current: 38.16
-103.1
38.5

More Statistics

Revenue (TTM) (Mil) $19,621
EPS (TTM) $ -1.93
Beta1.02
Short Percentage of Float28.21%
52-Week Range $14.06 - 34.08
Shares Outstanding (Mil)100.34

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 19,824 20,462 21,673
EPS ($) 1.21 1.69 2.31
EPS without NRI ($) 1.21 1.69 2.31
EPS Growth Rate
(Future 3Y To 5Y Estimate)
32.27%
Dividends per Share ($)
» More Articles for NYSE:THC

Headlines

Articles On GuruFocus.com
Amedisys Announces Definitive Agreement to Acquire Six Home Health and Hospice Care Centers from Ten Mar 01 2017 
8 of the Worst Stocks in Gurus' Portfolios Feb 20 2017 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
Health Canada Grants THC BioMed Oil Production License May 24 2016 
THC BioMed Enters Agreement for Installation of Affinor Vertical Farming System Apr 04 2016 
RETRANSMISSION: THC BioMed Enters Agreement for Installation of Affinor Vertical Farming System Apr 04 2016 
Health Canada Grants THC BioMed Licence to Cultivate Marihuana Feb 22 2016 
THC Closes $900,000 First Tranche Private Placement at $0.12 for 7,500,000 Units and Settles $90,600 Dec 10 2015 
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 

More From Other Websites
IAnthus CEO On Marijuana Legalization In U.S. And Canada: A Good Model Makes The Decision Easier Apr 21 2017
The Zacks Analyst Blog Highlights: Acadia Healthcare, Mednax and Tenet Healthcare Apr 19 2017
3 Hospital Stocks That Won't Make You Feel Better in Q1 Apr 18 2017
Why Snyder's-Lance, Incyte, and Tenet Healthcare Slumped Today Apr 17 2017
Tenet Healthcare, Community Health Systems plunge after HCA Holdings issues revenue, earnings... Apr 17 2017
Conifer Health Appoints Daniel Feldman Chief Compliance Officer Apr 13 2017
Final Trade: HA, SBUX & more Apr 12 2017
2 Hospital Stocks Set to Gain as Trumpcare's New Iteration Collapses Apr 10 2017
Here's Why You Should Dump Tenet Healthcare (THC) Stock Now Apr 10 2017
Wall Street Week Ahead: Is Chaos the New Normal? Apr 08 2017
Tenet to Report First Quarter Results on May 1 Apr 06 2017
Citigroup, Wells Fargo Upgraded; Tenet A Buy; Teradyne PT Hiked Apr 05 2017
Healthcare Stocks Sliding on Talks of Revived 'Trumpcare' Bill Apr 04 2017
10 Most Profitable For Profit Hospitals in America Mar 31 2017
About that GOP health reform, it was no big deal for health-care stocks in the first quarter Mar 31 2017
MCH Professional Care Chooses Conifer Health to Deliver Comprehensive Physician Revenue Cycle... Mar 30 2017
Tenet Healthcare (THC) Down 4.9% Since Earnings Report: Can It Rebound? Mar 30 2017
Renewed Obamacare Repeal Effort Sends Hospital Stocks Down Mar 28 2017
Hospital stocks tank as Republicans hope to revive Obamacare repeal Mar 28 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)